Inventor · disambiguated record
Lucas Horan
Also filed as: HORAN LUCAS
9 granted patents·7 pending applications·61 citations·filing 2016–2025
87Inventor score
Files withEUREKA THERAPEUTICS INC16
Top patents by PatentIndex Score
16 records- 0195US10822389B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted Nov 3, 2020·11 cites·22 claims
- 0294US10464988B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·16 cites·18 claims
- 0394US10098951B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·17 cites·46 claims
- 0492US10822413B2Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted Nov 3, 2020·13 cites·27 claims
- 0588US11421013B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Granted Aug 23, 2022·3 cites·20 claims
- 0681US11613573B2Chimeric antibody/T-cell receptor constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Mar 28, 2023·1 cites·19 claims
- 0781US2024317855A1Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereofEUREKA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0879US2022348629A1Antibody/t-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0978US2025361286A1Antibody/t-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1075US11976105B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·0 cites·20 claims
- 1174US2025011463A1Constructs targeting prostate-specific membrane antigen (psma) and uses thereofEUREKA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1265US11965021B2Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Apr 23, 2024·0 cites·23 claims
- 1361US11993661B2Constructs targeting prostate-specific membrane antigen (PSMA) and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted May 28, 2024·0 cites·25 claims
- 1448US2022265715A1Chimeric antigen receptor t cells and uses thereofEUREKA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1547US2022323497A1Cells expressing chimeric antigen receptors and chimeric stimulating receptors and uses thereofEUREKA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1647US2020255505A1Cells Expressing Cell Surface Receptors and AntibodiesEUREKA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →